The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Drontal Plus XL Tablets

175, 504, 525 mg/tablet Tablet

Vetoquinol SAVPA10521/006/002

Main Information

Trade NameDrontal Plus XL Tablets
Active SubstancesPyrantel embonate
Strength175, 504, 525 mg/tablet
Dosage FormTablet
Licence HolderVetoquinol SA
Licence NumberVPA10521/006/002

Group Information

ATC CodeQP52AC55 febantel, combinations
Therapeutic ClassEndoparasiticide


Licence Issued17/10/2003
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back